Skip to main content

Table 2 Clinical characteristics of patients with solid tumors and hematological malignancies

From: Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis

Characteristics

Solid tumors (n = 92)

Hematological malignancies (n = 16)

P value

Sex

0.54

 Male

50 (54.3)

10 (62.5)

 Female

42 (45.7)

6 (37.5)

Age groups

0.0039a

  ≤ 49 years

14 (15.2)

8 (50.0)

 50–64 years

28 (30.4)

6 (37.5)

 65–79 years

36 (39.1)

2 (12.5)

  ≥ 80 years

14 (15.2)

0 (0.0)

Comorbidities

 Hypertension

28 (30.4)

2 (12.5)

0.23

 Coronary heart disease

11 (12.0)

0 (0.0)

0.36

 Diabetes

11 (12.0)

0 (0.0)

0.36

 Chronic obstructive pulmonary disease

0 (0.0)

0 (0.0)

–

 Chronic kidney disease

0 (0.0)

0 (0.0)

–

 Cerebrovascular disease

1 (1.1)

0 (0.0)

1.0000

 Hepatitis

0 (0.0)

0 (0.0)

–

 Tuberculosis

1 (1.1)

0 (0.0)

1.0000

  1. aSignificant at P < 0.05